SEK 5.16
(2.18%)
Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
---|---|---|---|---|---|---|
Operating Cash Flow | -47.93 Million | -159.06 Million | 3.2 Million | 43.44 Million | -92.62 Million | -102.56 Million |
Net Income | -115.55 Million | -232.93 Million | -31.19 Million | -47.65 Million | -146.53 Million | -122.81 Million |
Depreciation & Amortization | 59.01 Million | 74.5 Million | 32.26 Million | 33.65 Million | 32.09 Million | 20.5 Million |
Deferred income taxes | - | - | -90 Thousand | -494 Thousand | -2.02 Million | 17.12 Million |
Stock-based compensation | 118 Thousand | - | 90 Thousand | 494 Thousand | 2.02 Million | 6.66 Million |
Change in working capital | -5.59 Million | -24.79 Million | -3.31 Million | 34.78 Million | -34.62 Million | -18.72 Million |
Other non-cash items | 137.82 Million | 24.16 Million | 5.44 Million | 22.67 Million | 56.43 Million | -5.32 Million |
Investing Cash Flow | -7.44 Million | -44.82 Million | -25.8 Million | -16.66 Million | -32.67 Million | -81.8 Million |
Investments in PPE | -7.57 Million | -50.25 Million | -27.48 Million | -24.78 Million | -38.46 Million | -90.82 Million |
Acquisitions | - | - | - | - | - | 65.47 Million |
Investment purchases | - | - | - | - | -191 Thousand | -371 Thousand |
Sales/Maturities of investments | - | - | - | - | - | 10 Thousand |
Other Investing Activities | 129 Thousand | 5.43 Million | 1.67 Million | 8.12 Million | 5.97 Million | -56.09 Million |
Financing Cash Flow | 84.85 Million | 132.84 Million | -16.93 Million | -10 Million | -16.51 Million | 357.16 Million |
Debt repayment | -295 Thousand | -4.01 Million | -5.66 Million | -5.1 Million | -9 Million | -3.3 Million |
Dividends payments | - | - | - | - | - | - |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | 98.05 Million | 102.56 Million | - | - | -53 Thousand | 376.3 Million |
Other Financing Activities | 1000.00 | 34.29 Million | -11.27 Million | -4.9 Million | -7.46 Million | -15.84 Million |
Accounts receivables | 27.29 Million | 6.08 Million | -19.87 Million | 4.8 Million | 25.74 Million | -25.24 Million |
Accounts payables | -35.48 Million | -24.02 Million | 25.54 Million | 33.13 Million | -48.99 Million | 31.17 Million |
Inventory | 2.59 Million | -6.84 Million | -8.98 Million | -3.15 Million | -11.37 Million | -24.65 Million |
Other working capital | 7.21 Million | -8.76 Million | -14.9 Million | -8.32 Million | 22.66 Million | 5.92 Million |
Cash at beginning of period | 33.09 Million | 83.51 Million | 133.6 Million | 106.22 Million | 248.75 Million | 84.17 Million |
Cash at end of period | 61.08 Million | 33.09 Million | 83.51 Million | 133.6 Million | 106.22 Million | 248.75 Million |
Capital Expenditure | -7.57 Million | -50.25 Million | -27.48 Million | -24.78 Million | -38.46 Million | -90.82 Million |
Effect of forex changes on cash | -1.49 Million | 4.31 Million | 3.3 Million | -8.43 Million | -434 Thousand | 1.05 Million |
Net cash flow / Change in cash | 27.98 Million | -50.41 Million | -50.09 Million | 27.38 Million | -142.52 Million | 164.58 Million |
Free Cash Flow | -55.5 Million | -209.32 Million | -24.28 Million | 18.65 Million | -131.09 Million | -193.39 Million |
Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | -9.42 Million | -17.26 Million | -115.55 Million | -31.9 Million | -32.67 Million | -35.56 Million |
Depreciation & Amortization | 9 Million | 9 Million | 59.01 Million | 7.55 Million | 7.25 Million | 36.72 Million |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | - | 118 Thousand | 118 Thousand | - | - |
Change in working capital | -19.81 Million | -19.81 Million | -5.59 Million | 34.14 Million | 18.35 Million | -26.54 Million |
Other non-cash items | 18.2 Million | 26.03 Million | 137.82 Million | -8.2 Million | 1.39 Million | -195 Thousand |
Investing Cash Flow | -711 Thousand | -711 Thousand | -7.44 Million | 568 Thousand | -640 Thousand | -2.27 Million |
Investments in PPE | -62.5 Thousand | -62.5 Thousand | -7.57 Million | 568 Thousand | -1.17 Million | -2.42 Million |
Acquisitions | - | - | - | - | - | - |
Investment purchases | - | - | - | - | - | - |
Sales/Maturities of investments | - | - | - | - | - | - |
Other Investing Activities | -648.5 Thousand | -648.5 Thousand | 129 Thousand | -338 Thousand | 539 Thousand | 148 Thousand |
Financing Cash Flow | -2.6 Million | -2.6 Million | 84.85 Million | -4.51 Million | -2.26 Million | 42.06 Million |
Debt repayment | - | - | -295 Thousand | -844 Thousand | -2.16 Million | -58.43 Million |
Dividends payments | - | - | - | - | - | - |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | - | - | 98.05 Million | - | -97 Thousand | 100.5 Million |
Other Financing Activities | -2.6 Million | -2.6 Million | 1000.00 | 1000.00 | -97 Thousand | 100.5 Million |
Accounts receivables | -20.86 Million | -20.86 Million | 27.29 Million | 35.71 Million | 13.66 Million | 444 Thousand |
Accounts payables | - | - | -35.48 Million | -20.33 Million | 1.71 Million | -2.58 Million |
Inventory | 2.02 Million | 2.02 Million | 2.59 Million | 18.75 Million | 2.97 Million | -24.4 Million |
Other working capital | -977.5 Thousand | -977.5 Thousand | 7.21 Million | 10.25 Million | 13.21 Million | -6.28 Million |
Cash at beginning of period | - | 61.07 Million | 33.09 Million | 45.87 Million | 54.63 Million | 40.34 Million |
Cash at end of period | -5 Million | 56.07 Million | 61.08 Million | 61.08 Million | 45.87 Million | 54.63 Million |
Capital Expenditure | -62.5 Thousand | -62.5 Thousand | -7.57 Million | 568 Thousand | -1.17 Million | -2.42 Million |
Effect of forex changes on cash | 341 Thousand | 341 Thousand | -1.49 Million | -1.47 Million | -186 Thousand | 86 Thousand |
Net cash flow / Change in cash | -5 Million | -5 Million | 27.98 Million | 15.2 Million | -8.76 Million | 14.29 Million |
Free Cash Flow | -2.09 Million | -2.09 Million | -55.5 Million | 21.19 Million | -6.85 Million | -27.99 Million |
0486
SBSW
NAR
ALPRO
603486
DCII